Recent Updates
Recently added Catalysts
LFCR Negative Sentiment Score: 25/100

Lifecore Biomedical, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 27, 2024 Deadline to file Lead Plaintiff Motion

Key Takeaway: Lifecore Biomedical, Inc. is facing a class action lawsuit for allegedly making false or misleading statements about its financial condition between October 7, 2020, and March 19, 2024. Investors are encouraged to file a lead plaintiff motion by September 27, 2024, to recover losses. The lawsuit claims Lifecore had inadequate internal controls and issued inaccurate financial statements, leading to a significantly overstated financial position. This situation has caused investors to suffer damages once accurate information was revealed.

Market Sentiment Analysis

CONCERNS & RISKS

  • Lifecore allegedly made false or misleading statements regarding financial reporting.
  • The company reportedly had inadequate internal controls over financial reporting.
  • Lifecore issued several inaccurate financial statements that required correction.
  • The financial position of Lifecore was significantly overstated, impacting investor trust.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Sept. 09, 2024 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises Lifecore Biomedical, Inc. ("Lifecore" or the "Company") (NASDAQ: LFCR) investors of a class action representing investors that bought securities between October 7, 2020 and March 19, 2024, inclusive (the "Class Period"). Lifecore investors have until September 27, 2024 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
According to the lawsuit, during the Class Period, the defendants allegedly made false or misleading statements and/or failed to disclose that: (1) Lifecore had inadequate internal controls over financial reporting; (2) as a result, Lifecore issued several inaccurate financial statements that would need to be corrected; (3) Lifecore's efforts to address these deficiencies were ineffective; (4) these issues hindered Lifecore's ability to file periodic reports with the Securities and Exchange Commission on time and meet NASDAQ listing requirements; (5) as a result, Lifecore's financial position and outlook were significantly overstated; and (6) consequently, Lifecore's public statements were materially false and misleading throughout the relevant period. The lawsuit claims that investors suffered damages once the true details became known.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising

Tags

Frequently Asked Questions

What is the deadline for Lifecore investors to file a motion?

Lifecore investors must file a lead plaintiff motion by September 27, 2024.

Who can Lifecore investors contact for legal help?

Investors can reach attorney Lesley F. Portnoy at 310-692-8883 or lesley@portnoylaw.com.

What misleading statements were made by Lifecore?

Lifecore allegedly made false statements about its financial controls and reporting.

Is there a cost for Lifecore investors to consult with your firm?

No, the Portnoy Law Firm offers a complimentary case evaluation for investors.

What is the basis for the class action against Lifecore?

The class action is based on Lifecore's misleading financial statements and reports.

Last updated: Sep 9, 2024